4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Lupin Limited (LUPIN) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 26,021 employees. Its market capitalization is roughly ₹952 billion. In the fiscal year ended 2026-03-31, LUPIN reported ₹274.9B in revenue and ₹53.3B in net income.
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | ₹274.9B | ₹221.9B | ₹196.6B | ₹162.7B |
| Gross Profit | ₹193.8B | ₹147.4B | ₹125.1B | ₹90.1B |
| Operating Income (EBIT) | ₹68.2B | ₹43.5B | ₹28.0B | ₹8.9B |
| Net Income | ₹53.3B | ₹32.8B | ₹19.1B | ₹4.3B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹82.2B | ₹73.9B | ₹71.0B | ₹61.6B | ₹55.6B | — |
| Gross Profit | ₹61.3B | ₹55.4B | ₹52.2B | ₹43.9B | ₹38.8B | — |
| Operating Income (EBIT) | ₹21.0B | ₹17.2B | ₹19.0B | ₹13.4B | ₹9.0B | — |
| Net Income | ₹14.2B | ₹14.6B | ₹11.8B | ₹12.2B | ₹7.7B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹5.5B) | (₹3.7B) | (₹1.8B) | (₹1.8B) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹383.6B | ₹292.0B | ₹240.0B | ₹229.6B | — |
| Total Liabilities | ₹158.5B | ₹119.1B | ₹96.2B | ₹104.1B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LUPIN viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms